After the learning curve, robotic pancreatoduodenectomy (RPD) demonstrated improved oncologic outcomes in patients with pancreatic duct adenocarcinoma (PDAC) compared to open pancreatoduodenectomy (OPD). A retrospective analysis of 548 patients revealed that RPD had longer overall survival (33.2 months vs. 25.7 months) and disease-free survival (18.5 months vs. 14.0 months) than OPD. RPD also had a lower incidence of local recurrence compared to OPD. Multivariate analysis confirmed RPD as an independent factor associated with improved survival. Prospective randomized trials are needed to validate these findings.
Journal Article by Chen H, Weng Y (…) Shen B et 5 al. in Surg Endosc
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.